These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7864860

  • 1. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
    Franzén P, Heldin CH, Miyazono K.
    Biochem Biophys Res Commun; 1995 Feb 15; 207(2):682-9. PubMed ID: 7864860
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
    Tam BY, Philip A.
    J Cell Physiol; 1998 Sep 15; 176(3):553-64. PubMed ID: 9699508
    [Abstract] [Full Text] [Related]

  • 3. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.
    Bassing CH, Shou W, Muir S, Heitman J, Matzuk MM, Wang XF.
    Cell Growth Differ; 1998 Mar 15; 9(3):223-8. PubMed ID: 9543388
    [Abstract] [Full Text] [Related]

  • 4. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor.
    Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R.
    Nature; 1995 Oct 12; 377(6549):548-52. PubMed ID: 7566156
    [Abstract] [Full Text] [Related]

  • 5. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
    He WW, Gustafson ML, Hirobe S, Donahoe PK.
    Dev Dyn; 1993 Feb 12; 196(2):133-42. PubMed ID: 8395914
    [Abstract] [Full Text] [Related]

  • 6. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
    De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Cancer Res; 1998 May 01; 58(9):1986-92. PubMed ID: 9581843
    [Abstract] [Full Text] [Related]

  • 7. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 01; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.
    EMBO J; 1997 Sep 01; 16(17):5353-62. PubMed ID: 9311995
    [Abstract] [Full Text] [Related]

  • 9. An emerging complexity of receptors for transforming growth factor-beta.
    Derynck R, Chen RH, Ebner R, Filvaroff EH, Lawler S.
    Princess Takamatsu Symp; 1994 Sep 01; 24():264-75. PubMed ID: 8983081
    [Abstract] [Full Text] [Related]

  • 10. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O, Goetschy JF, Horisberger M, Grütter MG.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):709-16. PubMed ID: 8713111
    [Abstract] [Full Text] [Related]

  • 11. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME, Datta PK, Moses HL.
    J Cell Biochem Suppl; 1998 Jul 25; 30-31():111-22. PubMed ID: 9893262
    [Abstract] [Full Text] [Related]

  • 12. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
    Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A.
    Oncogene; 2001 Jun 07; 20(26):3332-40. PubMed ID: 11423983
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of activation of the TGF-beta receptor.
    Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J.
    Nature; 1994 Aug 04; 370(6488):341-7. PubMed ID: 8047140
    [Abstract] [Full Text] [Related]

  • 14. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H.
    J Biol Chem; 1996 Feb 02; 271(5):2769-75. PubMed ID: 8576253
    [Abstract] [Full Text] [Related]

  • 15. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.
    Cárcamo J, Zentella A, Massagué J.
    Mol Cell Biol; 1995 Mar 02; 15(3):1573-81. PubMed ID: 7862150
    [Abstract] [Full Text] [Related]

  • 16. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J.
    Mol Cell Biol; 1994 Jun 02; 14(6):3810-21. PubMed ID: 8196624
    [Abstract] [Full Text] [Related]

  • 17. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.
    Wieser R, Attisano L, Wrana JL, Massagué J.
    Mol Cell Biol; 1993 Dec 02; 13(12):7239-47. PubMed ID: 8246946
    [Abstract] [Full Text] [Related]

  • 18. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
    Vivien D, Attisano L, Wrana JL, Massagué J.
    J Biol Chem; 1995 Mar 31; 270(13):7134-41. PubMed ID: 7706250
    [Abstract] [Full Text] [Related]

  • 19. Ligand-induced recruitment and phosphorylation of reduced TGF-beta type I receptor.
    Vivien D, Wrana JL.
    Exp Cell Res; 1995 Nov 31; 221(1):60-5. PubMed ID: 7589256
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL, Benya PD, Padilla SR, Carbonaro-Hall D, Williams R, Buckley S, Warburton D.
    Biochem J; 1996 May 15; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.